← Back to screener

Greenwich LifeSciences, Inc. GLSI

Rank #2427 · Nasdaq · $0.3B market cap
⚠ Going-concern flag — the auditor (MaloneBailey, LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
19.4
P/E
-14.7
P/B
38.14
ROE
-259.9%
Op. Margin
–%
Debt Ratio
48%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -14.7x, P/B 38.14x. Ranks in the top 86% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -259.9%. Ranks in the top 98% of the universe.

Safety ★★★★☆
Good

Debt ratio 48%. Ranks in the top 22% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2020–$-0.0B$-0.0B$-0.0B–-14
2021–$-0.0B$-0.0B$-0.0B–-77
2022–$-0.0B$-0.0B$0.0B–1
2023–$-0.0B$-0.0B$0.0B–1
2024–$-0.0B$-0.0B$0.0B–2
2025–$-0.0B$-0.0B$0.0B–48

← See the full screener